{"entity":{"type":"insider","cik":"0001654435","url":"/insider/0001654435","json_url":"/insider/0001654435.json","name":"Danziger Asaf","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":105,"n_filings":42,"first":"2016-03-04","last":"2023-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Danziger Asaf","source":"filing","n_filings":42,"first_seen":"2016-03-04","last_seen":"2023-01-09"}],"transactions":[{"id":8409131,"accession":"0001645113-23-000007","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187500.0,"shares_display":"187,500","price_per_share":108.0,"price_display":"108.00","price_state":"stated","total_value":20250000.0,"total_display":"20,250,000.00","shares_owned_after":13583.0,"shares_owned_after_display":"13,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409127,"accession":"0001645113-23-000007","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8369.0,"shares_display":"8,369","price_per_share":111.2338,"price_display":"111.23","price_state":"stated","total_value":930915.6722,"total_display":"930,915.67","shares_owned_after":30214.0,"shares_owned_after_display":"30,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409123,"accession":"0001645113-23-000007","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4568.0,"shares_display":"4,568","price_per_share":114.3524,"price_display":"114.35","price_state":"stated","total_value":522361.7632,"total_display":"522,361.76","shares_owned_after":23646.0,"shares_owned_after_display":"23,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409119,"accession":"0001645113-23-000007","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3702.0,"shares_display":"3,702","price_per_share":115.2113,"price_display":"115.21","price_state":"stated","total_value":426512.2326,"total_display":"426,512.23","shares_owned_after":19944.0,"shares_owned_after_display":"19,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409117,"accession":"0001645113-23-000007","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-8","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2123.0,"shares_display":"2,123","price_per_share":118.4714,"price_display":"118.47","price_state":"stated","total_value":251514.7822,"total_display":"251,514.78","shares_owned_after":15427.0,"shares_owned_after_display":"15,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409113,"accession":"0001645113-23-000007","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-7","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":112.8632,"price_display":"112.86","price_state":"stated","total_value":225726.4,"total_display":"225,726.40","shares_owned_after":28214.0,"shares_owned_after_display":"28,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409110,"accession":"0001645113-23-000007","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-6","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1395.0,"shares_display":"1,395","price_per_share":116.0618,"price_display":"116.06","price_state":"stated","total_value":161906.211,"total_display":"161,906.21","shares_owned_after":18549.0,"shares_owned_after_display":"18,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409105,"accession":"0001645113-23-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-5","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1344.0,"shares_display":"1,344","price_per_share":119.3493,"price_display":"119.35","price_state":"stated","total_value":160405.4592,"total_display":"160,405.46","shares_owned_after":14083.0,"shares_owned_after_display":"14,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409101,"accession":"0001645113-23-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-4","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":117.0111,"price_display":"117.01","price_state":"stated","total_value":116894.0889,"total_display":"116,894.09","shares_owned_after":17550.0,"shares_owned_after_display":"17,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8409097,"accession":"0001645113-23-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-23-000007","line_url":"/filing/0001645113-23-000007#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":119.987,"price_display":"119.99","price_state":"stated","total_value":59993.5,"total_display":"59,993.50","shares_owned_after":13583.0,"shares_owned_after_display":"13,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":4533293,"accession":"0001645113-21-000116","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-21-000116","line_url":"/filing/0001645113-21-000116#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3870.0,"shares_display":"3,870","price_per_share":102.36,"price_display":"102.36","price_state":"stated","total_value":396133.2,"total_display":"396,133.20","shares_owned_after":12172.0,"shares_owned_after_display":"12,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"},{"id":4533290,"accession":"0001645113-21-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000116","line_url":"/filing/0001645113-21-000116#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":103.37,"price_display":"103.37","price_state":"stated","total_value":103370.0,"total_display":"103,370.00","shares_owned_after":13172.0,"shares_owned_after_display":"13,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"},{"id":4533283,"accession":"0001645113-21-000116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000116","line_url":"/filing/0001645113-21-000116#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104.0,"shares_display":"104","price_per_share":96.5,"price_display":"96.50","price_state":"stated","total_value":10036.0,"total_display":"10,036.00","shares_owned_after":13276.0,"shares_owned_after_display":"13,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"},{"id":4280064,"accession":"0001645113-21-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000055","line_url":"/filing/0001645113-21-000055#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97973.0,"shares_display":"97,973","price_per_share":196.3431,"price_display":"196.34","price_state":"stated","total_value":19236322.5363,"total_display":"19,236,322.54","shares_owned_after":8184.0,"shares_owned_after_display":"8,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"},{"id":2828463,"accession":"0001628280-20-017710","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-25","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24973.0,"shares_display":"24,973","price_per_share":156.083,"price_display":"156.08","price_state":"stated","total_value":3897860.759,"total_display":"3,897,860.76","shares_owned_after":255407.0,"shares_owned_after_display":"255,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828459,"accession":"0001628280-20-017710","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-24","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24656.0,"shares_display":"24,656","price_per_share":157.037,"price_display":"157.04","price_state":"stated","total_value":3871904.272,"total_display":"3,871,904.27","shares_owned_after":231033.0,"shares_owned_after_display":"231,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828454,"accession":"0001628280-20-017710","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-23","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24286.0,"shares_display":"24,286","price_per_share":156.091,"price_display":"156.09","price_state":"stated","total_value":3790826.026,"total_display":"3,790,826.03","shares_owned_after":255689.0,"shares_owned_after_display":"255,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828448,"accession":"0001628280-20-017710","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-22","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23601.0,"shares_display":"23,601","price_per_share":157.007,"price_display":"157.01","price_state":"stated","total_value":3705522.207,"total_display":"3,705,522.21","shares_owned_after":231806.0,"shares_owned_after_display":"231,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828444,"accession":"0001628280-20-017710","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-21","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21612.0,"shares_display":"21,612","price_per_share":155.24,"price_display":"155.24","price_state":"stated","total_value":3355046.88,"total_display":"3,355,046.88","shares_owned_after":279975.0,"shares_owned_after_display":"279,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828438,"accession":"0001628280-20-017710","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-20","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21207.0,"shares_display":"21,207","price_per_share":155.232,"price_display":"155.23","price_state":"stated","total_value":3292005.024,"total_display":"3,292,005.02","shares_owned_after":280380.0,"shares_owned_after_display":"280,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828433,"accession":"0001628280-20-017710","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-19","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12092.0,"shares_display":"12,092","price_per_share":160.25,"price_display":"160.25","price_state":"stated","total_value":1937743.0,"total_display":"1,937,743.00","shares_owned_after":205258.0,"shares_owned_after_display":"205,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828429,"accession":"0001628280-20-017710","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-18","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11686.0,"shares_display":"11,686","price_per_share":160.27,"price_display":"160.27","price_state":"stated","total_value":1872915.22,"total_display":"1,872,915.22","shares_owned_after":205253.0,"shares_owned_after_display":"205,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828424,"accession":"0001628280-20-017710","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-17","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10077.0,"shares_display":"10,077","price_per_share":158.064,"price_display":"158.06","price_state":"stated","total_value":1592810.928,"total_display":"1,592,810.93","shares_owned_after":221729.0,"shares_owned_after_display":"221,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828421,"accession":"0001628280-20-017710","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-16","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9183.0,"shares_display":"9,183","price_per_share":158.094,"price_display":"158.09","price_state":"stated","total_value":1451777.202,"total_display":"1,451,777.20","shares_owned_after":221850.0,"shares_owned_after_display":"221,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828417,"accession":"0001628280-20-017710","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-15","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4790.0,"shares_display":"4,790","price_per_share":159.27,"price_display":"159.27","price_state":"stated","total_value":762903.3,"total_display":"762,903.30","shares_owned_after":216939.0,"shares_owned_after_display":"216,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828413,"accession":"0001628280-20-017710","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-14","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":159.323,"price_display":"159.32","price_state":"stated","total_value":716953.5,"total_display":"716,953.50","shares_owned_after":217350.0,"shares_owned_after_display":"217,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828409,"accession":"0001628280-20-017710","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-13","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4014.0,"shares_display":"4,014","price_per_share":161.106,"price_display":"161.11","price_state":"stated","total_value":646679.484,"total_display":"646,679.48","shares_owned_after":201239.0,"shares_owned_after_display":"201,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828405,"accession":"0001628280-20-017710","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":160.994,"price_display":"160.99","price_state":"stated","total_value":563479.0,"total_display":"563,479.00","shares_owned_after":201758.0,"shares_owned_after_display":"201,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828398,"accession":"0001628280-20-017710","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":162.353,"price_display":"162.35","price_state":"stated","total_value":276000.1,"total_display":"276,000.10","shares_owned_after":199539.0,"shares_owned_after_display":"199,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828394,"accession":"0001628280-20-017710","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1426.0,"shares_display":"1,426","price_per_share":162.173,"price_display":"162.17","price_state":"stated","total_value":231258.698,"total_display":"231,258.70","shares_owned_after":200332.0,"shares_owned_after_display":"200,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828390,"accession":"0001628280-20-017710","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":162.969,"price_display":"162.97","price_state":"stated","total_value":211859.7,"total_display":"211,859.70","shares_owned_after":199032.0,"shares_owned_after_display":"199,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828385,"accession":"0001628280-20-017710","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-8","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":971.0,"shares_display":"971","price_per_share":164.959,"price_display":"164.96","price_state":"stated","total_value":160175.189,"total_display":"160,175.19","shares_owned_after":198032.0,"shares_owned_after_display":"198,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828381,"accession":"0001628280-20-017710","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-7","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":165.383,"price_display":"165.38","price_state":"stated","total_value":115768.1,"total_display":"115,768.10","shares_owned_after":197832.0,"shares_owned_after_display":"197,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828378,"accession":"0001628280-20-017710","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-6","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":163.348,"price_display":"163.35","price_state":"stated","total_value":87554.528,"total_display":"87,554.53","shares_owned_after":199003.0,"shares_owned_after_display":"199,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828373,"accession":"0001628280-20-017710","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-5","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":164.109,"price_display":"164.11","price_state":"stated","total_value":82054.5,"total_display":"82,054.50","shares_owned_after":198532.0,"shares_owned_after_display":"198,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828369,"accession":"0001628280-20-017710","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-4","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":166.079,"price_display":"166.08","price_state":"stated","total_value":66431.6,"total_display":"66,431.60","shares_owned_after":197632.0,"shares_owned_after_display":"197,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2828364,"accession":"0001628280-20-017710","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-20-017710","line_url":"/filing/0001628280-20-017710#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":166.172,"price_display":"166.17","price_state":"stated","total_value":33234.4,"total_display":"33,234.40","shares_owned_after":197632.0,"shares_owned_after_display":"197,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2440504,"accession":"0001645113-20-000138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000138","line_url":"/filing/0001645113-20-000138#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103000.0,"shares_display":"103,000","price_per_share":99.0,"price_display":"99.00","price_state":"stated","total_value":10197000.0,"total_display":"10,197,000.00","shares_owned_after":197632.0,"shares_owned_after_display":"197,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-17","scope":"insider"},{"id":8076735,"accession":"0001645113-19-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-19-000014","line_url":"/filing/0001645113-19-000014#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103000.0,"shares_display":"103,000","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":9785000.0,"total_display":"9,785,000.00","shares_owned_after":134601.0,"shares_owned_after_display":"134,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-26","scope":"insider"},{"id":8351247,"accession":"0001209191-19-047965","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047965","line_url":"/filing/0001209191-19-047965#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65768.0,"shares_display":"65,768","price_per_share":91.604,"price_display":"91.60","price_state":"stated","total_value":6024611.872,"total_display":"6,024,611.87","shares_owned_after":135101.0,"shares_owned_after_display":"135,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-03","scope":"insider"},{"id":8351244,"accession":"0001209191-19-047965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047965","line_url":"/filing/0001209191-19-047965#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57913.0,"shares_display":"57,913","price_per_share":90.577,"price_display":"90.58","price_state":"stated","total_value":5245585.801,"total_display":"5,245,585.80","shares_owned_after":200869.0,"shares_owned_after_display":"200,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-03","scope":"insider"},{"id":8351238,"accession":"0001209191-19-047965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047965","line_url":"/filing/0001209191-19-047965#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":92.0,"price_display":"92.00","price_state":"stated","total_value":46000.0,"total_display":"46,000.00","shares_owned_after":134601.0,"shares_owned_after_display":"134,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-03","scope":"insider"},{"id":7927412,"accession":"0001209191-19-040204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-040204","line_url":"/filing/0001209191-19-040204#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187500.0,"shares_display":"187,500","price_per_share":62.15,"price_display":"62.15","price_state":"stated","total_value":11653125.0,"total_display":"11,653,125.00","shares_owned_after":258311.0,"shares_owned_after_display":"258,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-02","scope":"insider"},{"id":8067328,"accession":"0001209191-19-038449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-038449","line_url":"/filing/0001209191-19-038449#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":61.46,"price_display":"61.46","price_state":"stated","total_value":1536500.0,"total_display":"1,536,500.00","shares_owned_after":258311.0,"shares_owned_after_display":"258,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-21","scope":"insider"},{"id":8009494,"accession":"0001209191-19-037997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-037997","line_url":"/filing/0001209191-19-037997#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190338.0,"shares_display":"190,338","price_per_share":59.37,"price_display":"59.37","price_state":"stated","total_value":11300367.06,"total_display":"11,300,367.06","shares_owned_after":258311.0,"shares_owned_after_display":"258,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider"},{"id":8676200,"accession":"0001209191-19-036764","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-036764","line_url":"/filing/0001209191-19-036764#line-6","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18203.0,"shares_display":"18,203","price_per_share":55.735,"price_display":"55.74","price_state":"stated","total_value":1014544.205,"total_display":"1,014,544.20","shares_owned_after":258311.0,"shares_owned_after_display":"258,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-13","scope":"insider"},{"id":8676197,"accession":"0001209191-19-036764","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-036764","line_url":"/filing/0001209191-19-036764#line-5","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12233.0,"shares_display":"12,233","price_per_share":54.886,"price_display":"54.89","price_state":"stated","total_value":671420.438,"total_display":"671,420.44","shares_owned_after":276514.0,"shares_owned_after_display":"276,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-13","scope":"insider"},{"id":8676189,"accession":"0001209191-19-036764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-036764","line_url":"/filing/0001209191-19-036764#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15985.0,"shares_display":"15,985","price_per_share":54.71,"price_display":"54.71","price_state":"stated","total_value":874539.35,"total_display":"874,539.35","shares_owned_after":259161.0,"shares_owned_after_display":"259,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-13","scope":"insider"},{"id":8676186,"accession":"0001209191-19-036764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-036764","line_url":"/filing/0001209191-19-036764#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850.0,"shares_display":"850","price_per_share":55.425,"price_display":"55.42","price_state":"stated","total_value":47111.25,"total_display":"47,111.25","shares_owned_after":258311.0,"shares_owned_after_display":"258,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-13","scope":"insider"},{"id":8753916,"accession":"0001209191-19-017328","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-017328","line_url":"/filing/0001209191-19-017328#line-4","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001654435","owner_name":"Danziger Asaf","owner_url":"/insider/0001654435","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6441.0,"shares_display":"6,441","price_per_share":56.512,"price_display":"56.51","price_state":"stated","total_value":363993.792,"total_display":"363,993.79","shares_owned_after":233757.0,"shares_owned_after_display":"233,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"}],"next_cursor":"2019-03-04|8753916","ledger_fault":false,"count":{"value":105,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":101,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":105},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Director, Officer (Chief Executive Officer)","n_filings":42,"first_seen":"2016-03-04","last_seen":"2023-01-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001654435","retrieved_at":"2026-08-21T01:34:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}